Safety Data SheetChemical Risk Assessment

Tivicay Tablets

by ViiV Healthcare

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Tivicay Tablets is supplied by ViiV Healthcare under product code DOLUTEGRAVIR SODIUM TABLETS * GSK1349572A 10 MG TAB LETS * DOLUTEGRAVIR 10 MG FILM-COATED TABLET * DOLUTEGRAVIR 25 MG FILM-COA TED TABLET * DOLUTEGRAVIR 50 MG FILM-COATED TABLET * DOLUTEGRAVI R SODIUM, FORMULATED PRODUCT. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 8 May 2018. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.


Language
English
Regulation
GHS/CLP
Revision Date
08 May 2018
Signal Word
WARNING
Product Code
DOLUTEGRAVIR SODIUM TABLETS * GSK1349572A 10 MG TAB LETS * DOLUTEGRAVIR 10 MG FILM-COATED TABLET * DOLUTEGRAVIR 25 MG FILM-COA TED TABLET * DOLUTEGRAVIR 50 MG FILM-COATED TABLET * DOLUTEGRAVI R SODIUM, FORMULATED PRODUCT
CAS Number
9003-39-8,1051375-19-9,68130-99-4,13463-67-7

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: WARNING

Hazard Statements (H-phrases)
+548+EEC
See full Safety Data Sheet for the hazard statement wording.

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.


Common QuestionsAbout this Safety Data Sheet

Need help with Safety Data Sheets? You've come to the right place!

CONTACT US